Abstract

Since December 2019, a novel Severe Acute Respiratory Syndrome coronavirus 2 from China has rapidly spread worldwide. Although respiratory involvement is the mainstay of coronavirus disease 2019 (COVID-19), systemic involvement has recently drawn more attention. In particular, a number of recent articles have shed light on the nervous system as one of the possible targets. At our institution, we observed 15 patients with acute brain vascular manifestations; most interesting, we had a higher prevalence of the posterior circulation acute impairment. In our series, 7 patients had acute posterior cerebral injury: 1, hemorrhagic posterior reversible encephalopathy syndrome; 5, posterior circulation ischemic stroke; and 1, parieto-occipital hemorrhagic stroke. On the basis of our evidence and previous basic science reports, we believe a common etiopathogenetic thread may connect ischemic/hemorrhagic events of the posterior circulation and posterior reversible encephalopathy syndrome in the setting of COVID-19.

Highlights

  • ABBREVIATIONS: COVID-19 1⁄4 coronavirus disease 2019; PRES 1⁄4 posterior reversible encephalopathy syndrome; SARS-CoV-2 1⁄4 Severe Acute Respiratory

  • SARS-CoV-2 was found in the CSF in a patient diagnosed patient showed right parieto-occipital hemorrhagic stroke at with encephalitis, confirming its direct CNS invasion.[11] baseline; subsequent CTA ruled out vascular malformations or Other studies have highlighted imaging features of COVIDacute thrombosis

  • We found 5 ischeimaging showed progressive resorption of edema and hemor- mic strokes of the posterior circulation in line with other studies. rhages, in keeping with posterior reversible encephalopathy syn- Mao et al[5] described 4 cases of acute stroke, while others drome (PRES) (Fig 2)

Read more

Summary

Introduction

ABBREVIATIONS: COVID-19 1⁄4 coronavirus disease 2019; PRES 1⁄4 posterior reversible encephalopathy syndrome; SARS-CoV-2 1⁄4 Severe Acute Respiratory A growing number of studies have reported SARS-CoV-2 involvement of the CNS, showing a wide variety of neurologic symptoms.[4] According to a Chinese study, the incidence of neurologic symptoms was about 36% in a cohort of patients with COVID-19.5

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.